Blood Phobia Impact on Fainting
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial explores why some people faint when they see blood or receive an injection. It examines how the body's automatic responses to fear, such as changes in heart rate or blood pressure, contribute to this reaction. Participants will watch videos with either neutral or blood-related content (blood-injection-injury phobia stimuli) to observe their bodily reactions. This study may suit individuals who avoid medical visits due to a fear of needles or blood. As an unphased study, it offers a unique opportunity to contribute to understanding fear responses without the constraints of traditional clinical trial phases.
Do I need to stop my current medications to join the trial?
The trial does not specify if you need to stop taking your current medications, but you cannot participate if you are taking medication for a cardiovascular condition.
What prior data suggests that this protocol is safe?
Research shows that some people may faint when they see blood or needles. The body reacts to stress by lowering blood pressure, which can lead to fainting. This type of fainting, called vasovagal syncope, is triggered by emotional stress.
Many people with a fear of blood, injections, or injuries experience this reaction. However, fainting usually doesn't cause serious health problems. It's a temporary response and isn't harmful in the long run. People with this fear often have a heightened sensitivity to these situations, making them more likely to faint.
In summary, while fainting can be alarming, it is generally safe and doesn't cause lasting harm. The study aims to better understand these reactions and possibly find ways to help those affected.12345Why are researchers excited about this trial?
Researchers are excited about this trial because it explores the impact of visual stimuli on fainting in people with blood phobia. Unlike traditional treatments like cognitive behavioral therapy or medication, this approach uses targeted visual exposure to desensitize individuals to blood-injury-related stimuli. The method is unique because it directly assesses physiological responses to controlled stimuli, offering insights into fainting triggers and potentially leading to innovative, non-invasive treatment strategies.
What evidence suggests that this trial's treatments could be effective for blood phobia?
Research shows that people with a fear of blood, injections, or injuries often struggle with their body's automatic responses, increasing their likelihood of fainting. This phobia can lead to fainting due to a drop in blood pressure when they see blood or receive an injection. Women are more than twice as likely as men to experience this type of fainting. The trial will compare the effects of viewing blood-injection-injury (BII) phobia-related stimuli with neutral stimuli. Some treatments have reduced anxiety and fainting by altering these automatic responses when exposed to blood or injections. However, the exact mechanisms behind these reactions remain unclear.12467
Who Is on the Research Team?
Victoria E Claydon, PhD
Principal Investigator
Professor, Biomedical Physiology and Kinesiology
Are You a Good Fit for This Trial?
This trial is for English-speaking men and women aged 18 to 50 who either have or suspect they have a fear of needles (BII phobia) or do not. It's not open to those with heart or brain disorders, pregnant individuals, menopausal women, or anyone on heart medication.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Testing
Participants undergo a tilt test to assess cardiovascular reflex control and orthostatic tolerance on two separate days with different stimuli
Follow-up
Participants are monitored for safety and effectiveness after testing
What Are the Treatments Tested in This Trial?
Interventions
- Blood-injection-injury (BII) phobia stimuli
- Neutral stimuli
Find a Clinic Near You
Who Is Running the Clinical Trial?
Simon Fraser University
Lead Sponsor